Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
D 96.85 -1.29% -1.27
ABT closed down 1.29 percent on Friday, September 29, 2023, on 1.21 times normal volume.
Earnings due: Oct 17
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -1.29%
Lower Bollinger Band Walk Weakness -1.29%
Gapped Up Strength -1.29%
Oversold Stochastic Weakness -1.29%
Expansion Breakdown Bearish Swing Setup 1.38%
Lower Bollinger Band Walk Weakness 1.38%
Below Lower BB Weakness 1.38%
Down 3 Days in a Row Weakness 1.38%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Cancer Life Sciences Pain Infectious Diseases Diabetes Eye Pharmaceutical Products Inflammation Hypertension Influenza Hematology Glucose Lipid Lab Testing Vascular Disease Diagnostic Products Thyroid Health Care Products Fertility Immunoassay Blood Glucose Monitoring Cataracts Nutritional Products Contact Lens Fever Influenza Vaccine Irritable Bowel Syndrome Dyslipidemia Generic Pharmaceutical Vascular Products Cataract Surgery Generic Pharmaceuticals Data Management Software Lasik Lens Care Products Cholestasis Hypothyroidism Intrahepatic Cholestasis

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 115.83
52 Week Low 91.9272
Average Volume 4,263,514
200-Day Moving Average 105.29
50-Day Moving Average 104.37
20-Day Moving Average 100.09
10-Day Moving Average 98.32
Average True Range 1.66
RSI (14) 34.21
ADX 33.79
+DI 15.37
-DI 34.59
Chandelier Exit (Long, 3 ATRs) 100.09
Chandelier Exit (Short, 3 ATRs) 99.75
Upper Bollinger Bands 104.59
Lower Bollinger Band 95.59
Percent B (%b) 0.14
BandWidth 9.00
MACD Line -2.01
MACD Signal Line -1.75
MACD Histogram -0.2554
Fundamentals Value
Market Cap 171.65 Billion
Num Shares 1.77 Billion
EPS 1.89
Price-to-Earnings (P/E) Ratio 51.22
Price-to-Sales 5.95
Price-to-Book 6.07
PEG Ratio 3.38
Dividend 1.44
Dividend Yield 1.49%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 99.81
Resistance 3 (R3) 100.01 99.23 99.31
Resistance 2 (R2) 99.23 98.48 99.13 99.15
Resistance 1 (R1) 98.04 98.01 97.65 97.84 98.98
Pivot Point 97.26 97.26 97.07 97.16 97.26
Support 1 (S1) 96.07 96.51 95.68 95.87 94.72
Support 2 (S2) 95.29 96.04 95.19 94.55
Support 3 (S3) 94.10 95.29 94.39
Support 4 (S4) 93.90